OTCMKTS:APNHY ASPEN PHARMACAR/ADR Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ASPEN PHARMACAR/ADR Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.70 -0.05 (-0.74 %) (As of 09/25/2020 12:00 AM ET) Add Compare Share Today's Range$6.65Now: $6.70▼$6.7050-Day Range$6.75MA: $7.69▼$8.4952-Week Range$4.86Now: $6.70▼$9.25Volume701 shsAverage Volume2,682 shsMarket Capitalization$3.06 billionP/E Ratio6.70Dividend YieldN/ABeta1.39 ProfileAnalyst RatingsChartCompetitorsDividendHeadlinesShort InterestSocial Media Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products. It also provides various therapeutic products, including anaesthetics; and injectable anticoagulants comprising orgaran for the treatment of HIT under the Thrombosis brand. In addition, the company offers oncology, endocrinology, and women's health products, as well as consumer healthcare products. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ASPEN PHARMACAR/ADR. Previous Next 2.2 Community Rank Outperform VotesASPEN PHARMACAR/ADR has received 116 “outperform” votes. (Add your “outperform” vote.)Underperform VotesASPEN PHARMACAR/ADR has received 146 “underperform” votes. (Add your “underperform” vote.)Community SentimentASPEN PHARMACAR/ADR has received 55.73% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ASPEN PHARMACAR/ADR and other stocks. Vote “Outperform” if you believe APNHY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe APNHY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldASPEN PHARMACAR/ADR does not currently pay a dividend.Dividend GrowthASPEN PHARMACAR/ADR does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ASPEN PHARMACAR/ADR insiders have not sold or bought any company stock. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for ASPEN PHARMACAR/ADR are expected to grow by 6.82% in the coming year, from $0.88 to $0.94 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ASPEN PHARMACAR/ADR is 6.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 18.39.Price to Earnings Ratio vs. SectorThe P/E ratio of ASPEN PHARMACAR/ADR is 6.70, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.59.Price to Book Value per Share RatioASPEN PHARMACAR/ADR has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.94 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:APNHY Previous SymbolNASDAQ:APNHY CUSIPN/A CIKN/A Webwww.aspenpharma.com Phone27-31-580-8600Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio6.70 Forward P/E Ratio7.61 P/E GrowthN/A Sales & Book Value Annual Sales$2.74 billion Price / Sales1.12 Cash Flow$1.16 per share Price / Cash Flow5.80 Book Value$8.38 per share Price / Book0.80Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees10,000 Outstanding Shares456,452,000Market Cap$3.06 billion Next Earnings Date9/30/2020 (Estimated) OptionableNot Optionable $6.70 -0.05 (-0.74 %) (As of 09/25/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive APNHY News and Ratings via Email Sign-up to receive the latest news and ratings for APNHY and its competitors with MarketBeat's FREE daily newsletter. ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) Frequently Asked Questions How has ASPEN PHARMACAR/ADR's stock price been impacted by COVID-19 (Coronavirus)? ASPEN PHARMACAR/ADR's stock was trading at $6.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, APNHY shares have decreased by 0.7% and is now trading at $6.70. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of ASPEN PHARMACAR/ADR? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ASPEN PHARMACAR/ADR in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for ASPEN PHARMACAR/ADR. When is ASPEN PHARMACAR/ADR's next earnings date? ASPEN PHARMACAR/ADR is scheduled to release its next quarterly earnings announcement on Wednesday, September 30th 2020. View our earnings forecast for ASPEN PHARMACAR/ADR. Are investors shorting ASPEN PHARMACAR/ADR? ASPEN PHARMACAR/ADR saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 1,500 shares, an increase of 50.0% from the August 15th total of 1,000 shares. Based on an average trading volume of 1,800 shares, the days-to-cover ratio is currently 0.8 days. View ASPEN PHARMACAR/ADR's Short Interest. Who are some of ASPEN PHARMACAR/ADR's key competitors? Some companies that are related to ASPEN PHARMACAR/ADR include MONOTARO CO LTD/ADR (MONOY), Sonic Healthcare (NNGRY), DAVIDE CAMPARI-/S (DVDCY), BRAMBLES LTD/S (BXBLY), Recordati (RCDTF), AJINOMOTO INC/ADR (AJINY), EDENRED S A/ADR (EDNMY), Bureau Veritas (BVRDF), Halma (HLMAF), LEG Immobilien (LEGIF), NITTO DENKO COR/ADR (NDEKY), SAGE GRP PLC/GDR (SGPYY), DiaSorin (DSRLF), KUMBA IRON OR/S (KIROY) and GN STORE NORD A/ADR (GNNDY). View all competitors. Who are ASPEN PHARMACAR/ADR's key executives? ASPEN PHARMACAR/ADR's management team includes the following people: Mr. Stephen Bradley Saad, Group CEO & Exec. Director (Age 55)Mr. Michael Guy Attridge, Deputy Group Chief Exec. & Exec. Director (Age 58)Mr. Sean M. Capazorio, Group Fin. Officer (Age 52)Ms. Lorraine Hill, Group Operating Officer (Age 55)Mr. Riaan Verster BProc, LLM, LLB, ACIS, Company Sec., Group Governance Officer & Group Compliance Officer (Age 43) What is ASPEN PHARMACAR/ADR's stock symbol? ASPEN PHARMACAR/ADR trades on the OTCMKTS under the ticker symbol "APNHY." How do I buy shares of ASPEN PHARMACAR/ADR? Shares of APNHY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ASPEN PHARMACAR/ADR's stock price today? One share of APNHY stock can currently be purchased for approximately $6.70. How big of a company is ASPEN PHARMACAR/ADR? ASPEN PHARMACAR/ADR has a market capitalization of $3.06 billion and generates $2.74 billion in revenue each year. The company earns $455.64 million in net income (profit) each year or $1.00 on an earnings per share basis. ASPEN PHARMACAR/ADR employs 10,000 workers across the globe. What is ASPEN PHARMACAR/ADR's official website? The official website for ASPEN PHARMACAR/ADR is www.aspenpharma.com. How can I contact ASPEN PHARMACAR/ADR? ASPEN PHARMACAR/ADR's mailing address is 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge, Durban T3, 4051. The company can be reached via phone at 27-31-580-8600. This page was last updated on 9/26/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
